Go Deep
Connect Biopharma Holdings Limited
Connect Biopharma Holdings Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,911 | -0.8 | 2.15 | 0.02 | 87.50 |
| Oct 2026 | 22,935 | -0.8 | 2.13 | 0.02 | 86.31 |
| Oct 2026 | 21,734 | -0.8 | 2.12 | 0.02 | 86.05 |
| Oct 2026 | 22,942 | -0.8 | 2.12 | 0.02 | 85.84 |
| Oct 2026 | 22,958 | -0.8 | 2.11 | 0.02 | 85.32 |
| Oct 2026 | 23,019 | -0.7 | 2.05 | 0.02 | 82.98 |
| Oct 2026 | 23,211 | -0.7 | 1.87 | 0.02 | 75.49 |
| Oct 2026 | 23,300 | -0.6 | 1.79 | 0.02 | 71.94 |
Connect Biopharma Holdings Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,768,000.0 | 169,000.0 | 0.0 | 16,000.0 |
| Net Profit | -17,284,000.0 | -19,398,000.0 | -15,109,000.0 | -17,200,000.0 |
| EPS | -0.3 | -0.3 | -0.3 | -0.3 |
Connect Biopharma Holdings Limited Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 64,000.0 | 26,033,000.0 | 0.0 | 0.0 | — |
| Net Profit | -55,480,000.0 | -15,628,000.0 | -62,106,000.0 | -118,091,000.0 | — |
| EPS | -1.0 | -0.3 | -1.1 | -2.1 | — |
Connect Biopharma Holdings Limited Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 56,075,000.0 | 101,284,000.0 | 127,375,000.0 | 174,013,000.0 | — |
| Total Liabilities | 14,095,000.0 | 9,118,000.0 | 25,878,000.0 | 16,521,000.0 | — |
| Total Equity | 41,980,000.0 | 92,166,000.0 | 101,497,000.0 | 157,492,000.0 | — |
Owes vs Owns
Connect Biopharma Holdings Limited owed $0.38 for every $1 it owned in Jun 2026, up from $0.09 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.38× | 0.25× | 0.09× | 0.20× | 0.09× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Connect Biopharma Holdings Limited Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 79.1%Fixed assets (tangible) 7.9%Other assets 12.6%
How it's funded — Dec 2025
Short-term debt 0.6%Long-term debt 0.7%Payables 3.5%Other liabilities 20.4%Shareholders' equity 74.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 44.3 | 93.7 | 118.3 | 152.4 |
| Receivables | 0.2 | 1.1 | 0.4 | 0.2 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 4.5 | 4.2 | 4.7 | 5.4 |
| Intangible assets | 0.0 | 0.1 | 0.1 | 3.2 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 9.4 |
| Other assets | 7.1 | 2.2 | 3.9 | 3.4 |
| Liabilities & equity | ||||
| Short-term debt | 0.3 | 0.2 | 0.3 | 0.2 |
| Long-term debt | 0.4 | 0.0 | 0.2 | 0.2 |
| Payables | 2.0 | 0.3 | 2.2 | 11.9 |
| Other liabilities | 11.4 | 8.6 | 23.2 | 4.2 |
| Shareholders' equity | 42.0 | 92.2 | 101.5 | 157.5 |
| Net tangible assets | 41.9 | 92.1 | 101.4 | 154.3 |
Connect Biopharma Holdings Limited Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -51,206,000.0 | -23,612,000.0 | -47,741,000.0 | -101,520,000.0 | — |
| Investing Activities | 9,818,000.0 | -3,451,000.0 | 74,980,000.0 | -86,243,000.0 | — |
| Financing Activities | 1,093,000.0 | 227,000.0 | 45,000.0 | -85,000.0 | — |